JP2000093166A - Bacillus bifidus growth promoting substance derived from albumen, and food containing the substance - Google Patents
Bacillus bifidus growth promoting substance derived from albumen, and food containing the substanceInfo
- Publication number
- JP2000093166A JP2000093166A JP10271819A JP27181998A JP2000093166A JP 2000093166 A JP2000093166 A JP 2000093166A JP 10271819 A JP10271819 A JP 10271819A JP 27181998 A JP27181998 A JP 27181998A JP 2000093166 A JP2000093166 A JP 2000093166A
- Authority
- JP
- Japan
- Prior art keywords
- egg white
- bifidobacteria
- substance
- albumen
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明はビフィズス菌および
乳酸菌の増殖促進物質、当該物質を含有する食品、当該
物質を用いるビフィズス菌および乳酸菌の増殖方法並び
に当該物質をビフィズス菌および/または乳酸菌あるい
はビフィズス菌および/または乳酸菌を含有する食品と
ともに培養、発酵させて得られる発酵食品に関する。The present invention relates to a substance for promoting the growth of bifidobacteria and lactic acid bacteria, a food containing the substance, a method for growing bifidobacteria and lactic acid bacteria using the substance, and a method for producing the substance by using bifidobacteria and / or lactic acid bacteria or bifidobacteria. And / or a fermented food obtained by culturing and fermenting with a food containing lactic acid bacteria.
【0002】[0002]
【従来の技術】卵は周知のごとく、牛乳と並んで完全栄
養食品の一つとされ、その高次機能について数多くの研
究がなされている。これらの多くは主に卵黄成分を対象
としており、卵白に関する研究は立ち遅れていた。近
年、卵白の高次機能に関する研究も行われ始め、抗菌作
用の他に抗腫瘍作用、免疫賦活化作用、抗ウイルス作用
等が明らかにされ、その一部は既に特殊飼料として販売
されているものも存在する。2. Description of the Related Art As is well known, eggs are one of the complete nutritional foods along with milk, and many studies have been made on their higher functions. Many of these were primarily aimed at the yolk component, and studies on egg white were lagging behind. In recent years, studies on higher-order functions of egg white have begun to be carried out, and in addition to antibacterial effects, antitumor effects, immunostimulatory effects, antiviral effects, etc. have been revealed, some of which have already been sold as special feed. Also exists.
【0003】本発明者らは従来より卵の研究に従事して
おり、卵黄や卵白の特殊成分の各機能について明らかに
している(特願平5−5279397、特願平7−28
5885、特願平9−173018、大綱弘ら、医学と
生物学、126(1),19−23,1993)。[0003] The present inventors have been engaged in research on eggs and have clarified the functions of special components of egg yolk and egg white (Japanese Patent Application Nos. 5-529797 and 7-28).
5885, Japanese Patent Application No. 9-173018, Hiroshi Ohna et al., Medicine and Biology, 126 (1), 19-23, 1993).
【0004】[0004]
【発明が解決しようとする課題】上記研究の中で、本発
明者らは、卵白のある成分を動物に経口投与すると明ら
かに糞便の性状が改善されるという経験を有していた。
糞便の性状の改善とはすなわち、腸内環境の改善に起因
すると考えられることから、卵白を種々の成分に分画し
それらのビフィズス菌や乳酸菌に対する影響を調べ、卵
白の加水分解物にビフィズス菌や乳酸菌、特にビフィズ
ス菌の増殖を非常に強く促進させる作用があることを見
いだし本発明を完成するに至った。In the above studies, the present inventors had the experience that the oral administration of certain components of egg white to animals clearly improved the fecal properties.
Since the improvement of fecal properties is considered to be due to the improvement of the intestinal environment, egg white is fractionated into various components and their effects on bifidobacteria and lactic acid bacteria are examined. And lactic acid bacteria, especially bifidobacteria, have an effect of promoting the growth very strongly, and have completed the present invention.
【0005】ビフィズス菌は、下痢症、便秘症、感染症
等の予防、治療効果や腸内の有害細菌の増殖抑制作用等
から腸内の有用細菌であることが一般に知られている。
腸内環境の改善は健康維持に必須であることから、ビフ
ィズス菌やその増殖因子を含有する食品や医薬品が数多
く開発されている。ビフィズス菌を含有する食品として
最も一般的なものはヨーグルトに代表される発酵食品で
あるが、これらの食品は共存する乳酸菌が産生する酸に
より発酵直後からビフィズス菌数が急速に減少し、1週
間後にはほとんど検出できなくなることが指摘されてい
た(湧口浩也,酪農化学・食品の研究,vol 33,A2
03−A212,1984)。このような背景から、増
殖促進活性が高く、ビフィズス菌の活性を保持しうる増
殖因子の研究・開発が多くの研究機関で勢力的に続けら
れ、現在ではその特異な栄養要求性から主に炭素源に焦
点を当てたオリゴ糖の研究・開発が主体となっている。
しかし、従来よりビフィズス因子はカゼイン加水分解物
やある種の微生物代謝産物など数多くの物質が報告され
ており、より安価な原料と簡易な製造法によるビフィズ
ス菌増殖因子の開発が求められている。Bifidobacterium is generally known to be a useful bacterium in the intestine because of its preventive and therapeutic effects on diarrhea, constipation, infectious diseases and the like, and its inhibitory effect on the growth of harmful bacteria in the intestine.
Since the improvement of the intestinal environment is essential for maintaining health, many foods and pharmaceuticals containing bifidobacteria and their growth factors have been developed. The most common foods containing bifidobacteria are fermented foods represented by yogurt, but the number of bifidobacteria rapidly decreases from immediately after fermentation due to the acid produced by coexisting lactic acid bacteria, It was later pointed out that it could hardly be detected (Hiroya Wakiguchi, Dairy Chemistry and Food Research, vol 33, A2
03-A212, 1984). Against this background, research and development of growth factors that have high growth-promoting activity and can maintain the activity of bifidobacteria have been vigorously continued at many research institutions. The main research and development of oligosaccharides is focused on the source.
However, a large number of substances such as casein hydrolysates and certain types of microbial metabolites have been reported as bifidobacteria, and there has been a demand for the development of bifidobacteria growth factors using cheaper raw materials and a simple production method.
【0006】[0006]
【課題を解決するための手段】本発明は、蛋白分解酵素
で処理した卵白を有効成分として含有することを特徴と
するビフィズス菌および乳酸菌の増殖促進物質を提供す
る。SUMMARY OF THE INVENTION The present invention provides a growth promoting substance for bifidobacteria and lactic acid bacteria, which comprises, as an active ingredient, egg white treated with a protease.
【0007】また、本発明は、前記増殖促進物質を含有
することを特徴とする食品を提供する。[0007] The present invention also provides a food containing the growth promoting substance.
【0008】さらに、本発明は、前記増殖物質を用いる
ことを特徴とするビフィズス菌および乳酸菌の増殖方法
を提供する。Further, the present invention provides a method for growing bifidobacteria and lactic acid bacteria, which comprises using the above-mentioned growth substance.
【0009】さらに加えて、本発明は、前記増殖促進物
質をビフィズス菌および/または乳酸菌あるいはビフィ
ズス菌および/または乳酸菌を含有する食品とともに培
養、発酵させて得られる発酵食品を提供する。[0009] In addition, the present invention provides a fermented food obtained by culturing and fermenting the growth promoting substance with a bifidobacterium and / or lactic acid bacterium or a food containing the bifidobacterium and / or lactic acid bacterium.
【0010】[0010]
【発明の実施の形態】本発明の卵白加水分解物はビフィ
ズス菌の増殖を顕著に促進し、特に乳酸菌との共培養に
おいてもビフィズス菌の増殖促進作用を有しており、卵
白加水分解物にこのようなビフィズス菌増殖促進作用が
存在することは全く知られていなかった。本発明はヨー
グルトの発酵時間の短縮やビフィズス菌のヨーグルト内
での増殖などを可能とし、ビフィズス菌および乳酸菌を
含有するあらゆる食品に対して極めて有効な物質であ
る。また、腸内細菌叢をビフィズス菌優勢にするために
もオリゴ糖に代わるビフィズス因子として期待できるも
のと考えられる。BEST MODE FOR CARRYING OUT THE INVENTION The egg white hydrolyzate of the present invention remarkably promotes the growth of bifidobacteria, and particularly has the effect of promoting the growth of bifidobacteria even in co-culture with lactic acid bacteria. It was not known at all that such a bifidobacterium growth promoting action was present. INDUSTRIAL APPLICABILITY The present invention enables shortening of fermentation time of yogurt, growth of bifidobacteria in yogurt, and the like, and is a very effective substance for all foods containing bifidobacteria and lactic acid bacteria. In addition, it is considered that the intestinal flora can be expected to be a bifidobacterium alternative to oligosaccharides in order to make bifidobacteria dominant.
【0011】本発明のビフィズス菌および乳酸菌の増殖
促進物質を食品に含有させる場合は、合計量(重量基
準)に対して当該物質を0.01〜5.0%、好ましく
は0.15〜1.0%含有させることができる。対象と
する食品としては、特に限定されないが、ヨーグルト、
ヨーグルト飲料、乳酸菌飲料、その他のビフィズス菌お
よび/または乳酸菌を含有する食品を挙げることができ
る。When the foodstuffs of the present invention contain a substance for promoting the growth of bifidobacteria and lactic acid bacteria, the substance is contained in an amount of 0.01 to 5.0%, preferably 0.15 to 1%, based on the total amount (weight basis). 0.0%. Target foods are not particularly limited, but include yogurt,
Examples include yogurt drinks, lactic acid bacteria drinks, and other foods containing bifidobacteria and / or lactic acid bacteria.
【0012】また、前記増殖促進物質をビフィズス菌お
よび/または乳酸菌あるいはビフィズス菌および/また
は乳酸菌を含有する食品とともに培養、発酵させて発酵
食品を製造する場合、最終製品の重量に対して、当該物
質の含有量が0.01〜5.0%、好ましくは0.15
〜1.0%、さらに好ましくは0.3〜0.6%となる
ように添加すると良い。In the case where the above-mentioned growth promoting substance is cultured and fermented together with bifidobacteria and / or lactic acid bacteria or food containing bifidobacteria and / or lactic acid bacteria, a fermented food is produced. Is 0.01 to 5.0%, preferably 0.15%
To 1.0%, more preferably 0.3 to 0.6%.
【0013】[0013]
【実施例】次に本発明を実施例にて詳細に説明する。
尚、以下に記載する実施例は本発明を説明するだけのも
のであり、酵素やその反応条件などを実施例の記述に限
定するものではない。Next, the present invention will be described in detail with reference to examples.
It should be noted that the examples described below are only for explaining the present invention, and do not limit the enzymes and their reaction conditions to those described in the examples.
【0014】[0014]
【実施例1】 卵白 Bifidus Factor(卵白BF)の製
造 卵白BFの調製 鶏卵卵白を脱イオン水で2〜3倍に希釈し、pHを蛋白
質分解酵素の至適pH(8.0)に調整した後、卵白量
の0.01〜1%(好ましくは0.1%)の蛋白質分解
酵素(アクチナーゼAS;科研製薬(株)を加え、37
℃で18時間、ゆっくり撹拌しながら反応させた。次い
で、撹拌しながら、80〜90℃、30分間の加熱処理
にて酵素反応を停止させた。熱凝固物質を除去して得ら
れた清澄液を凍結乾燥または噴霧乾燥した。このアクチ
ナーゼ処理卵白を卵白Bifidus Factor(以下卵白BFと
略記)とした。Example 1 Production of Egg White Bifidus Factor (Egg White BF) Preparation of Egg White BF Chicken egg egg white was diluted 2-3 times with deionized water, and the pH was adjusted to the optimal pH (8.0) for the protease. Thereafter, a proteolytic enzyme (actinase AS; Kaken Pharmaceutical Co., Ltd.) of 0.01 to 1% (preferably 0.1%) of the amount of egg white is added, and 37
The reaction was carried out at 18 ° C. for 18 hours with slow stirring. Next, the enzymatic reaction was stopped by a heat treatment at 80 to 90 ° C. for 30 minutes while stirring. The clarified liquid obtained by removing the heat-coagulated substance was freeze-dried or spray-dried. This actinase-treated egg white was defined as egg white Bifidus Factor (hereinafter abbreviated as egg white BF).
【0015】さらに、蛋白質分解酵素の種類により活性
に違いがあるかどうかを調べるためアクチナーゼASの
代わりにトリプシン(Sigma社製)、パパイン(Sigma社
製、タイプIV)とプロナーゼK(科研化学社製)を用
いて、上記の方法に準じて卵白を処理し調製した。各々
トリプシン処理画分、パパイン処理画分、プロナーゼK
処理画分とした。Further, in order to examine whether there is a difference in the activity depending on the type of the protease, trypsin (manufactured by Sigma), papain (manufactured by Sigma, type IV) and pronase K (manufactured by Kaken Kagaku) were used instead of actinase AS. ) Was prepared by treating egg white according to the above method. Trypsin-treated fraction, papain-treated fraction, pronase K
This was the treated fraction.
【0016】未分解卵白の調製 鶏卵卵白を同量の脱イオン水で希釈し、85℃、30分
間の加熱処理を行なった。直ちに、氷冷水中で冷却した
後、熱凝固物質を除去した。得られた清澄液を噴霧乾燥
し、未分解卵白粉末を得た。Preparation of Undegraded Egg White Chicken egg white was diluted with the same amount of deionized water, and heated at 85 ° C. for 30 minutes. Immediately after cooling in ice-cold water, the heat-coagulated material was removed. The obtained clear liquid was spray-dried to obtain undegraded egg white powder.
【0017】脱脂卵白BFの調製 アセトン脱水の後、クロロホルム・メタノール(2:
1)で完全に脱脂、乾燥した卵白BFを使用した。Preparation of defatted egg white BF After dehydration with acetone, chloroform / methanol (2:
Egg white BF completely defatted and dried in 1) was used.
【0018】脂溶性画分の調製 上記の有機溶媒可溶物を減圧下(エバポレーター)に
て処理し、有機溶媒を完全に除去した。これを少量のジ
メチルスルホキシド(DMSO)に溶解し、脂溶性画分
として用いた。Preparation of fat-soluble fraction The above organic solvent-soluble matter was treated under reduced pressure (evaporator) to completely remove the organic solvent. This was dissolved in a small amount of dimethyl sulfoxide (DMSO) and used as a fat-soluble fraction.
【0019】糖鎖画分の調製 卵白BFを酵素で徹底的に分解し、糖鎖のみを残した試
料を調製した。すなわち記載の脱脂卵白BFを10%
濃度に脱イオン水で溶解し、pHを8.0に調整した。
パパイン(Sigma社製、タイプIV)とプロナーゼK
(科研化学社製)を加え蛋白質を酵素消化した。分解物
にトリクロロ酢酸(TCA)を最終濃度が10%になる
ように加え、氷冷水中で10分間冷却した。遠心分離に
て沈殿物を除去し、凍結乾燥した。乾燥物に99.5%
エタノールを加え、TCAを除去した。Preparation of Sugar Chain Fraction Egg white BF was thoroughly decomposed with an enzyme to prepare a sample in which only the sugar chain was left. That is, 10% of the defatted egg white BF described
Dissolved in deionized water to a concentration and adjusted the pH to 8.0.
Papain (Sigma, Type IV) and Pronase K
(Manufactured by Kaken Chemical Co., Ltd.) was added and the protein was digested with enzymes. Trichloroacetic acid (TCA) was added to the decomposition product to a final concentration of 10%, followed by cooling in ice-cold water for 10 minutes. The precipitate was removed by centrifugation and freeze-dried. 99.5% on dry matter
Ethanol was added to remove TCA.
【0020】ビフィズス菌増殖促進活性の測定 培養はヨーグルトスターターABT−1(CHR.Hansen
社)より分離したビフィズス菌(Bifidobacterium lact
is)を使用し、10%スキムミルク培地(3ml)に、
フィルター滅菌済み各卵白BF溶液(最終濃度0.6
%)を0.2ml加え、前培養した菌液を10倍希釈
し、0.1ml添加後、滅菌流動パラフィンを重層し、
培養(37℃、24時間)した。スキムミルク培地はオ
ートクレープ処理後、流水中で急冷して脱気したものを
用いた。Measurement of Bifidobacterium growth promoting activity Culture was carried out using a yogurt starter ABT-1 (CHR. Hansen
Bifidobacterium lact
is) using 10% skim milk medium (3 ml)
Filtered sterilized egg white BF solution (final concentration 0.6
%), The precultured bacterial solution was diluted 10-fold, 0.1 ml was added, and sterilized liquid paraffin was overlaid.
The cells were cultured (37 ° C., 24 hours). The skim milk medium used was deaerated by quenching in running water after autoclaving.
【0021】培養液中の菌体数の測定は培養終了後適宜
希釈した培養液100μlをビフィズス菌選択平板培地
(5% NNLP溶液含有MRS寒天培地;Merck KGaA
製)に塗抹し、嫌気的条件下で37℃、48時間培養に
て検出した。なお、NNLP溶液の組成を下記表1に示
す。The number of cells in the culture was measured by appropriately diluting 100 μl of the culture after the completion of the culture with a selective plate medium for bifidobacteria (MRS agar medium containing 5% NNLP solution; Merck KGaA).
) And detected by culturing at 37 ° C for 48 hours under anaerobic conditions. The composition of the NNLP solution is shown in Table 1 below.
【0022】[0022]
【表1】 結果[Table 1] result
【表2】 卵白BF、各酵素で処理した卵白、未分解卵白、脱脂卵
白BF、脂溶性画分および糖鎖画分のそれぞれのビフィ
ズス菌増殖促進作用を上記表2に示した。糖鎖画分、脂
溶性画分および未分解卵白には活性は認められなかった
が、アクチナーゼ処理した卵白BFと各プロテアーゼ処
理画分および脱脂卵白BFにはビフィズス菌増殖促進作
用が認められた。各種プロテアーゼ処理した卵白はアク
チナーゼ処理した卵白BFとほぼ同等の活性が認められ
ることから、卵白はプロテアーゼ処理されることにより
ビフィズス菌増殖促進活性を示し、その活性は卵白中の
糖類や脂溶性物質等ではなく、蛋白質の分解物(ペプチ
ド)であることが確認された。現在までにペプチド性の
ビフィズス菌増殖促進物質は牛乳カゼインの酵素分解物
がいくつか報告されているが、卵白由来のものは未だ報
告されていなかった。[Table 2] The above-mentioned Table 2 shows the bifidobacterium growth-promoting effects of egg white BF, egg white treated with each enzyme, undegraded egg white, defatted egg white BF, fat-soluble fraction and sugar chain fraction. No activity was observed in the sugar chain fraction, the fat-soluble fraction and undegraded egg white, but the actinase-treated egg white BF, the protease-treated fraction and the defatted egg white BF showed an activity of promoting the growth of bifidobacteria. Egg whites treated with various proteases have almost the same activity as egg white BF treated with actinase. Therefore, egg whites show bifidobacterial growth promoting activity when treated with proteases. However, it was confirmed that it was not a protein degradation product (peptide). Up to now, some peptide-derived bifidobacterial growth promoting substances have been reported to be enzymatically decomposed products of milk casein, but those derived from egg white have not been reported yet.
【0023】上記の試験からも明らかなように、プロテ
アーゼの種類によるビフィズス菌増殖促進作用の差はほ
とんど認められないことから、以後の実施例ではアクチ
ナーゼ処理卵白(卵白BF)を用いて試験を行った。
尚、以下に記載する実施例は本発明を説明する為だけの
ものであり、サンプルや各試験の条件などを実施例の記
述に限定するものではない。As is evident from the above test, there is almost no difference in the effect of promoting the growth of bifidobacteria depending on the type of protease. Therefore, in the following examples, the test was carried out using actinase-treated egg white (egg white BF). Was.
The examples described below are only for explaining the present invention, and do not limit the samples, the conditions of each test, and the like to the descriptions of the examples.
【0024】[0024]
【実施例2】卵白BFの各種ビフィズス菌増殖促進作用 各種ビフィズス菌に及ぼす影響を、それぞれ単独培養で
検討した。Example 2 Effect of Egg White BF on Proliferation of Various Bifidobacteria The effect on various Bifidobacteria was examined by single culture.
【0025】使用菌株 ヒト腸管由来のビフィズス菌5株を用いた。全ての菌株
は理化学研究所より購入したもので、純粋培養後、それ
ぞれの合成培地で前培養(最低3回継代培養を繰り返
す)し、本培養に用いた。下記表3に菌株と前培養用合
成培地を示す。Bacteria used Five strains of bifidobacteria derived from human intestine were used. All strains were purchased from RIKEN. After pure culture, they were pre-cultured (repeated at least 3 times) in each synthetic medium and used for main culture. Table 3 below shows the strains and the synthetic medium for preculture.
【0026】[0026]
【表3】 培養 先の試験とほぼ同様に行なった。すなわち、10%スキ
ムミルク培地(3ml)に、フィルター滅菌済み卵白B
F溶液(最終濃度0.6および0.3%)を0.2ml
加えた。さらに、それぞれ前培養した菌液を10倍希釈
し、0.1ml添加後、滅菌流動パラフィンを重層し、
培養(37℃、24時間)した。スキムミルク培地はオ
ートクレープ処理後、流水中で急冷して脱気したものを
用いた。 菌数測定 培養液を適宜10倍希釈を行ない、それぞれの選択培地
に塗抹、培養後、出現コロニー数より、スキムミルク培
地1mlあたりの菌数を算出した。各菌株の検出用寒天
培地を表3に示す。[Table 3] The test was performed in substantially the same manner as the test in the culture destination. That is, filter-sterilized egg white B was added to 10% skim milk medium (3 ml).
0.2 ml of F solution (final concentrations 0.6 and 0.3%)
added. Further, the pre-cultured bacterial solution was diluted 10-fold, and after adding 0.1 ml, sterilized liquid paraffin was overlaid,
The cells were cultured (37 ° C., 24 hours). The skim milk medium used was deaerated by quenching in running water after autoclaving. Measurement of the number of bacteria The culture solution was appropriately diluted 10-fold, smeared on each selective medium, cultured, and the number of bacteria per 1 ml of skim milk medium was calculated from the number of appearing colonies. Table 3 shows the agar medium for detection of each strain.
【0027】結果Result
【表4】 ビフィズス菌に対する結果を表4に示した。ビフィズス
菌の菌種によってかなりの差が認められるが、全ての菌
株に対して10倍以上の増殖促進活性が認められた。特
に、B.adolescentis、 B.infntis には強い活性が認めら
れた。[Table 4] The results for Bifidobacterium are shown in Table 4. Although a considerable difference was observed depending on the type of Bifidobacterium, a growth promoting activity of 10 times or more was observed for all strains. In particular, strong activity was observed for B. adolescentis and B. infntis.
【0028】これらの結果から、卵白BFはビフィズス
菌を10〜100倍のレベルで増殖させるため、ビフィ
ズス菌優勢の腸内菌叢の形成が期待される。From these results, since egg white BF grows bifidobacteria at a level of 10 to 100 times, it is expected that intestinal flora predominant in bifidobacteria is predominant.
【0029】[0029]
【実施例3】 乳酸菌との共培養 実施例1および2の結果、卵白BFはビフィズス菌に対
し高い増殖促進作用を示すことが明らかとなった。そこ
で本発明による卵白BFが乳酸菌と共培養したビフィズ
ス菌に対してどのように作用するかについて、実施例1
で得た卵白BFのビフィズス菌および乳酸菌増殖促進作
用について未分解卵白と比較検討した。 供試検体 実施例1で得た卵白BFおよび未分解卵白を使用した。Example 3 Co-culture with Lactic Acid Bacteria The results of Examples 1 and 2 revealed that egg white BF had a high growth promoting effect on Bifidobacteria. Example 1 describes how the egg white BF according to the present invention acts on bifidobacteria co-cultured with lactic acid bacteria.
The growth promoting effect of the egg white BF obtained in Example 2 on the growth of bifidobacteria and lactic acid bacteria was compared with that of undegraded egg white. Test sample Egg white BF and undegraded egg white obtained in Example 1 were used.
【0030】供試菌体 下記の菌を含むヨーグルトスターターABT−1(CHR.
Hansen社)を使用した。Test cells The yoghurt starter ABT-1 (CHR.
Hansen).
【0031】 Lactobacillus acidophilus(L.acidophilus) Streptococcus thermophilus(S.thermophilus) Bifidobacterium bifidum(B.bifidum) Bifidobacterium lactis(B.lactis) 上記のABT−1を滅菌生理食塩水で1%濃度に懸濁し
スターター液とした。 培養 10%スキムミルク培地(110℃、10分、オートク
レーブ処理)3mlに、各濃度(最終濃度:0.3およ
び0.6%)に調製した卵白BF液を0.2ml添加
し、スターター液を0.1ml添加した。撹拌後、40
℃で6時間培養した。なお、卵白BF液の代わりに、同
一濃度の未分解卵白溶液を加えたものを対照(コントロ
ール)とした。Lactobacillus acidophilus (L. acidophilus) Streptococcus thermophilus (S. thermophilus) Bifidobacterium bifidum (B. bifidum) Bifidobacterium lactis (B. lactis) The above ABT-1 is suspended in sterile physiological saline to a concentration of 1% and a starter solution is prepared. And Culture To 3 ml of 10% skim milk medium (110 ° C., 10 minutes, autoclave treatment), 0.2 ml of egg white BF solution prepared at each concentration (final concentration: 0.3 and 0.6%) was added, and the starter solution was added to 0 ml. .1 ml was added. After stirring, 40
Cultured at 6 ° C for 6 hours. In addition, what added the same density | concentration undegraded egg white solution instead of the egg white BF liquid was set as the control.
【0032】菌体数の測定 ビフィズス菌数の測定は実施例1に記載した方法に準じ
て行った。Measurement of Number of Bacteria The number of Bifidobacteria was measured according to the method described in Example 1.
【0033】L.acidophilus はMRSマルトース寒天培
地を用い、37℃、48時間培養にて検出した。S.ther
mophilus は Lee's寒天培地を用い、43℃、48時間
培養にて検出した。なお、Lee's寒天培地の組成を下記
表5に示す。L. acidophilus was detected by culturing at 37 ° C. for 48 hours using MRS maltose agar medium. S.ther
mophilus was detected by using Lee's agar medium at 43 ° C. for 48 hours. The composition of Lee's agar medium is shown in Table 5 below.
【0034】[0034]
【表5】 結果[Table 5] result
【表6】 卵白BFをスキムミルク培地に、0.3および0.6%
濃度になるように調製して培養した結果を上記表6に示
した。酵素加水分解した卵白BFに増殖促進活性が認め
られた。ビフィズス菌に対する増殖促進作用は非常に顕
著なもので、0.6%添加で無添加および未分解卵白添
加時の約20,000倍に達し、効果の高いビフィズス
菌増殖促進物質であることが確認された。また、乳酸菌
に対しても0.6%添加で1.5〜2.5倍の増殖促進
作用が認められた。[Table 6] Egg white BF in skim milk medium, 0.3 and 0.6%
Table 6 shows the results of cultivation after adjusting to a concentration. Enzymatically hydrolyzed egg white BF showed a growth promoting activity. The growth-promoting effect on Bifidobacteria is very remarkable, reaching about 20,000 times the addition of 0.6% and the addition of undegraded egg white, confirming that it is a highly effective Bifidobacterium growth-promoting substance. Was done. In addition, the addition of 0.6% to lactic acid bacteria showed a 1.5- to 2.5-fold growth promoting effect.
【0035】[0035]
【実施例4】 卵白BF濃度によるビフィズス菌増殖促
進活性の変化実施例3に示すように卵白BFに顕著なビ
フィズス菌増殖促進活性が認められることから、その活
性についてさらに詳細に検討を加えた。Example 4 Change in Bifidobacterium Growth-Promoting Activity According to Egg White BF Concentration As shown in Example 3, egg white BF has a remarkable bifidobacterium growth-promoting activity. Therefore, the activity was examined in more detail.
【0036】供試検体 実施例1で得た卵白BFを使用した。Test sample The egg white BF obtained in Example 1 was used.
【0037】供試菌体 実施例3と同様ヨーグルトスターターABT−1(CHR.
Hansen社)を使用した。Test cells As in Example 3, the yoghurt starter ABT-1 (CHR.
Hansen).
【0038】培養 各濃度(最終濃度:0, 0.015, 0.0375,
0.075, 0.15,0.3, 0.6, 1.2, 2.4
および5.0%)に調製した卵白BFのビフィズス菌増
殖促進活性を実施例3に準じて測定した。Culture Each concentration (final concentration: 0, 0.015, 0.0375,
0.075, 0.15, 0.3, 0.6, 1.2, 2.4
And 5.0%) of the egg white BF was measured for the activity of promoting the growth of bifidobacteria in accordance with Example 3.
【0039】菌体数の測定 実施例3に準じて行った。Measurement of the number of bacterial cells The measurement was performed according to Example 3.
【0040】結果Result
【表7】 卵白BFをスキムミルク培地に、0.015〜5.0%
濃度になるように調製して培養した結果を上記表7に示
した。0.15%から0.6%まで濃度依存的にビフィ
ズス菌増殖促進活性が認められ、0.6%以上の濃度で
その増殖はプラトーに達した。0.6%添加でコントロ
ールの約20,000倍に達し、非常に効果の高いビフ
ィズス菌増促進物質であることが確認された。[Table 7] Egg white BF in skim milk medium, 0.015 to 5.0%
Table 7 shows the results obtained by culturing the cells after adjusting the concentration. Bifidobacterium growth promoting activity was observed in a concentration-dependent manner from 0.15% to 0.6%, and the growth reached a plateau at a concentration of 0.6% or more. The addition of 0.6% reached about 20,000 times that of the control, confirming that the substance is a very effective bifidobacteria increase promoting substance.
【0041】[0041]
【実施例5】 ヨーグルトの製造 ヨーグルトの製造 市販成分無調整乳に、卵白BFを0.6%量添加、溶解
し、加熱殺菌(80℃、15分)した。殺菌後、氷冷水
中にて40℃に冷却し、牛乳1lあたり約300mgの
スターター(ABT−1)を添加した。撹拌後、直ち
に、100ml容のカップに分注し、アルミシールで密
封し、発酵(40℃、7時間)させた。また、卵白BF
を加えなかったものをコントロールとした。Example 5 Production of Yogurt Production of Yogurt Egg white BF was added to commercially available unregulated milk in an amount of 0.6%, dissolved, and heat-sterilized (80 ° C., 15 minutes). After sterilization, the mixture was cooled to 40 ° C. in ice-cold water, and about 300 mg of starter (ABT-1) was added per liter of milk. Immediately after stirring, the mixture was dispensed into a 100 ml cup, sealed with an aluminum seal, and fermented (40 ° C., 7 hours). Also, egg white BF
A control without adding was used as a control.
【0042】pHの測定 pHはpHメーター(pH METER F−22:
(株)堀場製作所)を用い、スターター添加時を0時間
とし、1時間毎に経時的に測定した。Measurement of pH The pH was measured with a pH meter (pH METER F-22:
Using Horiba, Ltd.), the time when the starter was added was set to 0 hour, and the measurement was made over time every hour.
【0043】酸度の測定 酸度は滴定法にて測定し、乳酸酸度に換算した。スター
ター添加時を0時間とし、1時間毎に経時的に測定し
た。Measurement of acidity The acidity was measured by a titration method and converted to lactic acidity. The time at which the starter was added was set to 0 hour, and the measurement was made over time every hour.
【0044】菌数測定 各菌体数は実施例3と同様の方法で、スターター添加時
を0時間とと、1時間毎に経時的に測定した。Measurement of the Number of Bacteria The number of cells was measured in the same manner as in Example 3 with the starter added at 0 hour and hourly over time.
【0045】結果 pH、酸度の変化を図1に、各菌数の変化を図2に示し
た。卵白BF添加時の方が明らかにpHの低下、酸度お
よび菌数の上昇が速いことが確認された。特にビフィズ
ス菌において、対照では時間の経過と共に菌数の減少が
認められるのに対し、卵白BF添加では菌数の上昇が認
められ、図2に示したように発酵終了時の菌数はビフィ
ズス菌で対照に対し200倍程度の増殖促進活性が認め
られた。また、乳酸菌においても2〜3倍の増殖促進活
性が確認された。Results Changes in pH and acidity are shown in FIG. 1, and changes in the number of bacteria are shown in FIG. It was confirmed that when the egg white BF was added, the pH, the acidity and the number of bacteria increased more clearly. In particular, in the case of bifidobacteria, the number of bacteria decreased with the passage of time in the control, whereas the number of bacteria increased when egg white BF was added, and as shown in FIG. Showed a growth promoting activity about 200 times that of the control. In addition, the growth promoting activity of lactic acid bacteria was confirmed to be two to three times.
【0046】これらの結果から、卵白BFの添加はビフ
ィズス菌に酸耐性を付与し、ヨーグルト製造中でもビフ
ィズス菌の増殖を可能とするだけではなく、スターター
の乳酸菌(L.acidophilus,S.thermophilus)にも増殖促
進作用を示し、その結果、速いpHの低下、酸度の上昇
を導いていることを示している。From these results, the addition of egg white BF not only imparts acid resistance to bifidobacteria and enables the growth of bifidobacteria even during the production of yogurt, but also adds to the starter lactic acid bacteria (L. acidophilus, S. thermophilus). Also show a growth promoting effect, resulting in a rapid decrease in pH and an increase in acidity.
【0047】[0047]
【発明の効果】上述のように、本発明の卵白由来ビフィ
ズス菌増殖促進物質は、ビフィズス菌に対し他に類をみ
ない強い活性を持っていた。これを利用することで、ヨ
ーグルトの発酵時間の短縮、ビフィズス菌のヨーグルト
内での増殖などが可能になり、ビフィズス菌および乳酸
菌を含有するあらゆる製品に対して極めて有効な物質で
ある。また、腸内菌叢をビフィズス菌優勢にするために
もオリゴ糖に代わるビフィズス因子として期待できるも
のである。As described above, the egg white-derived bifidobacterium growth-promoting substance of the present invention has a unique activity against bifidobacteria. By utilizing this, it is possible to shorten the fermentation time of yogurt and to grow bifidobacteria in yogurt, etc., and it is a very effective substance for all products containing bifidobacteria and lactic acid bacteria. In addition, it can be expected as a bifidogenic factor replacing oligosaccharides in order to make the intestinal flora dominant in bifidobacteria.
【図1】 ヨーグルト発酵中のpHおよび酸度の変化を
示すグラフである。FIG. 1 is a graph showing changes in pH and acidity during yoghurt fermentation.
【図2】 ヨーグルト発酵中の菌体数の変化を示すグラ
フである。FIG. 2 is a graph showing a change in the number of cells during fermentation of yogurt.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 大石 一二三 東京都立川市西砂町3−15−24 Fターム(参考) 4B001 AC05 AC31 AC50 BC14 EC99 4B018 LB07 MD72 MD87 ME11 MF13 4B065 AA21X AA30X AA49X BB19 BB34 CA42 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Ichizo Oishi 3-15-24 Nishisunacho, Tachikawa-shi, Tokyo F-term (reference) 4B001 AC05 AC31 AC50 BC14 EC99 4B018 LB07 MD72 MD87 ME11 MF13 4B065 AA21X AA30X AA49X BB19 BB34 CA42
Claims (7)
として含有することを特徴とするビフィズス菌および乳
酸菌の増殖促進物質。1. A growth-promoting substance for bifidobacteria and lactic acid bacteria, comprising as an active ingredient egg white treated with a protease.
%含有することを特徴とする食品。2. The method according to claim 1, wherein the substance is 0.01 to 5.0.
% Food.
求項2記載の食品。3. The food according to claim 2, containing 0.3 to 1.0% of said substance.
3記載の食品。4. The food according to claim 2, wherein the food is yogurt.
とするビフィズス菌および乳酸菌の増殖方法。5. A method for growing bifidobacteria and lactic acid bacteria, comprising using the substance according to claim 1.
び/または乳酸菌あるいはビフィズス菌および/または
乳酸菌を含有する食品とともに培養、発酵させて得られ
る発酵食品。6. A fermented food obtained by culturing and fermenting the substance according to claim 1 together with a bifidobacterium and / or lactic acid bacterium or a food containing the bifidobacterium and / or lactic acid bacterium.
6記載の発酵食品。7. The fermented food according to claim 6, wherein the fermented food is yogurt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10271819A JP2000093166A (en) | 1998-09-25 | 1998-09-25 | Bacillus bifidus growth promoting substance derived from albumen, and food containing the substance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10271819A JP2000093166A (en) | 1998-09-25 | 1998-09-25 | Bacillus bifidus growth promoting substance derived from albumen, and food containing the substance |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000093166A true JP2000093166A (en) | 2000-04-04 |
Family
ID=17505299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10271819A Pending JP2000093166A (en) | 1998-09-25 | 1998-09-25 | Bacillus bifidus growth promoting substance derived from albumen, and food containing the substance |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000093166A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005074703A1 (en) * | 2004-02-10 | 2005-08-18 | Join Co. Ltd | A process for preparing an egg white liquid for prevention of coagulation due to heat treatment |
JP2007189914A (en) * | 2006-01-17 | 2007-08-02 | Kitasato Gakuen | Bifidobacteria proliferation-promoting peptide |
JP2009284850A (en) * | 2008-05-30 | 2009-12-10 | Q P Corp | High-protein gel-like food |
JP2010220565A (en) * | 2009-03-24 | 2010-10-07 | Q P Corp | Cake |
JP2011107080A (en) * | 2009-11-20 | 2011-06-02 | Eiken Chemical Co Ltd | Specimen sampling instrument set |
JP2014068599A (en) * | 2012-09-28 | 2014-04-21 | Morikawa Kenkodo Kk | Method of producing royal jelly having lactobacillus proliferation promoting action |
JP2017514527A (en) * | 2014-05-09 | 2017-06-08 | コオペラティ・アヴェベ・ユー・エイ | Yogurt production |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57146546A (en) * | 1981-03-06 | 1982-09-10 | Eisai Co Ltd | Production of fermented dairy products |
JPS63209542A (en) * | 1987-02-25 | 1988-08-31 | Karupisu Shokuhin Kogyo Kk | Preparation of fermented milk containing bifidus bacterium |
JPH05336954A (en) * | 1992-06-05 | 1993-12-21 | Eisai Co Ltd | Method for culturing microorganism and medium for microorganism |
JPH06133689A (en) * | 1992-10-23 | 1994-05-17 | Snow Brand Milk Prod Co Ltd | Fermented milk low in water separability and its production |
-
1998
- 1998-09-25 JP JP10271819A patent/JP2000093166A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57146546A (en) * | 1981-03-06 | 1982-09-10 | Eisai Co Ltd | Production of fermented dairy products |
JPS63209542A (en) * | 1987-02-25 | 1988-08-31 | Karupisu Shokuhin Kogyo Kk | Preparation of fermented milk containing bifidus bacterium |
JPH05336954A (en) * | 1992-06-05 | 1993-12-21 | Eisai Co Ltd | Method for culturing microorganism and medium for microorganism |
JPH06133689A (en) * | 1992-10-23 | 1994-05-17 | Snow Brand Milk Prod Co Ltd | Fermented milk low in water separability and its production |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005074703A1 (en) * | 2004-02-10 | 2005-08-18 | Join Co. Ltd | A process for preparing an egg white liquid for prevention of coagulation due to heat treatment |
JP2007189914A (en) * | 2006-01-17 | 2007-08-02 | Kitasato Gakuen | Bifidobacteria proliferation-promoting peptide |
JP4726129B2 (en) * | 2006-01-17 | 2011-07-20 | 学校法人北里研究所 | Bifidobacterium growth-promoting peptide |
JP2009284850A (en) * | 2008-05-30 | 2009-12-10 | Q P Corp | High-protein gel-like food |
JP2010220565A (en) * | 2009-03-24 | 2010-10-07 | Q P Corp | Cake |
JP2011107080A (en) * | 2009-11-20 | 2011-06-02 | Eiken Chemical Co Ltd | Specimen sampling instrument set |
JP2014068599A (en) * | 2012-09-28 | 2014-04-21 | Morikawa Kenkodo Kk | Method of producing royal jelly having lactobacillus proliferation promoting action |
JP2017514527A (en) * | 2014-05-09 | 2017-06-08 | コオペラティ・アヴェベ・ユー・エイ | Yogurt production |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Champagne et al. | Challenges in the addition of probiotic cultures to foods | |
KR100704441B1 (en) | Lactobacillus helvetius producing antihypertensive di- and tripeptides | |
TWI739495B (en) | Composition for promoting defecation and use therefor | |
KR101927859B1 (en) | Method for improving the stability and coating efficiency of probiotics using ultrasonic wave after freeze-drying and food composition containing freeze-dried powder of probiotics prepared thereby as effective component | |
KR20060135016A (en) | Compostion comprising yucca extract, quillaia extract and lactic acid bacterium and food and drink containing the composition | |
PT1893033E (en) | Method for preparing a dairy analogue | |
JP2009296910A (en) | Bifidobacterium bacillus-containing composition and method for producing the bifidobacterium bacillus-containing composition | |
WO2004089109A1 (en) | Feed composition | |
Haldar et al. | Development of vacuum‐dried probiotic milk powder with Bacillus coagulans | |
JP2000093166A (en) | Bacillus bifidus growth promoting substance derived from albumen, and food containing the substance | |
JP2004051530A (en) | Intestinal flora-improving agent and food or drink containing the same | |
JP4115181B2 (en) | Method for enhancing immunostimulatory effect of lactic acid bacteria | |
WO2008003781A1 (en) | Method and medium for preserving lactic acid bacteria in a viable state | |
JP4780565B2 (en) | Lactic acid bacteria culture medium | |
JPH0515366A (en) | Proliferation promoter for lactic acid bacterium and bifidobacterium | |
JP4688457B2 (en) | Immune enhancing composition | |
JP4307026B2 (en) | Lactic acid bacteria growth promoter and process for producing the same | |
JPH08187072A (en) | Food preserving agent and production thereof | |
WO2009150888A1 (en) | Milk protein degradation product, manufacturing method for milk protein degradation product and bifidobacterial growth-promoting agent | |
JP7544461B2 (en) | Composition for improving survival of bifidobacteria | |
JP2022057336A (en) | Method for Producing Composition Containing Aromatic Lactic Acid | |
JP3993322B2 (en) | Lactic acid bacteria growth promoter and use thereof | |
KR20100010557A (en) | A method for preparing a culture medium comprising a powdered skim milk as a main ingredient for culturing lactic acid bacteria | |
JPH08187071A (en) | Method for preserving food | |
Santiago-López et al. | Probiotic Potential of Bacteria Isolated from Huauzontle (Chenopodium berlandieri spp. Nuttalliae) and Multifunctional Properties of Their Intracellular Contents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050819 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050819 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080513 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080714 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090218 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100326 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100628 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100817 |
|
A912 | Removal of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20101203 |